twymeeg

Lyon, France, sep 30, 2024 – Poxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG® Royalties for USD 50 million DOWNLOAD Poxel press release   

Osaka, Japan & Lyon, France, aug 07, 2024 – Sumitomo Pharma and Poxel Announce Topline Results from Post-MarketingClinical Study on TWYMEEG® for the Treatment of Type 2 Diabetes in Japan DOWNLOAD Poxel press release